{"body": "A technology executive turned to ChatGPT and other AI tools to help develop a personalized cancer vaccine for his terminally ill dog, The Australian reported this week. Working outside any formal research institution, he used the tools to parse scientific literature, design experimental protocols, and identify candidate treatment strategies — work that would typically require years of specialist training and access to a well-funded lab.\n\nPersonalized cancer vaccines target the specific mutations present in an individual tumor. They are among the most scientifically active areas of modern oncology and have attracted serious investment from companies including Moderna and BioNTech in the human medicine space. Applying the approach to a companion animal is less orthodox, but veterinary oncology has seen genuine growth in immunotherapy research over the past decade. Regulatory requirements for experimental veterinary treatments are also considerably lighter than for human trials, which likely made the project viable to pursue without institutional backing.\n\nThe outcome for the dog has not been confirmed. What is clear is that this was not a simple prompt-and-answer exercise: the executive appears to have used AI as a genuine research partner over an extended period, working through the same scientific reasoning a specialist would apply. The Australian did not name him.\n\nA growing number of technically minded people with no formal biomedical background are doing similar things — using LLMs to move faster through literature and experimental design than was previously possible without a PhD and a lab. The risks are real: AI-generated biomedical guidance can be wrong, and self-directed experimental treatment on animals sits in a legal and ethical grey area even where oversight is minimal. But the tools are already out there, and <a href=\"/news/2026-03-14-chatgpt-cancer-vaccine-dog\">this case</a> is unlikely to be the last of its kind."}